S
0.429
0.01 (3.22%)
| Previous Close | 0.416 |
| Open | 0.404 |
| Volume | 1,026,079 |
| Avg. Volume (3M) | 1,270,185 |
| Market Cap | 8,899,948 |
| Price / Earnings (TTM) | 0.001 |
| Price / Sales | 0.010 |
| Price / Book | 0.390 |
| 52 Weeks Range | |
| Earnings Date | 15 May 2025 |
| Operating Margin (TTM) | -9,178.81% |
| Diluted EPS (TTM) | 786.48 |
| Quarterly Revenue Growth (YOY) | -72.60% |
| Total Debt/Equity (MRQ) | 45.28% |
| Current Ratio (MRQ) | 0.720 |
| Operating Cash Flow (TTM) | -3.99 M |
| Levered Free Cash Flow (TTM) | 6.83 M |
| Return on Assets (TTM) | -10.33% |
| Return on Equity (TTM) | -82.95% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Farm Products (US) | Bearish | Mixed |
| Farm Products (Global) | Bearish | Mixed | |
| Stock | Shineco, Inc. | - | - |
AIStockmoo Score
-0.4
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.5 |
| Average | -0.38 |
|
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food. |
|
| Sector | Consumer Defensive |
| Industry | Farm Products |
| Investment Style | Small Value |
| % Held by Insiders | 25.00% |
| % Held by Institutions | 0.50% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Powell Investment Advisors, Llc | 31 Mar 2025 | 27,888 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 11 Jun 2025 | Announcement | Management Confidence: Shineco Executives Launch up to $2M Open-Market Stock Purchase Program |
| 13 May 2025 | Announcement | Shineco’s Subsidiary InfiniClone Partners with Total World Marketing for Entry into the Southeast Asian Healthcare Market |
| 23 Apr 2025 | Announcement | Shineco Announces Acquisition of Singapore Evolutionary Stem Cell Company |
| 25 Mar 2025 | Announcement | Shineco Announces Acquisition of Medical Device Company |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |